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Introduction 
The male sexual dysfunction includes three components, namely-  
− erectile dysfunction (ED);  
− ejaculatory dysfunction (EjD); and  
− hypoactive desire (HD); loss of desire or decreased desire. 
All these symptoms are seen common in elderly. Until recently, it was widely assumed that 
symptoms of male sexual dysfunction were a natural consequence of the aging process. A 
decrease in sexual function and sexual activity is not an inevitable consequence of aging. 
Older individuals retain significant interest in sexuality and a large proportion of older men 
and women remain sexually active. 1, 2 Furthermore, sexuality is a factor that correlates with 
individuals’ perception of their well-being and quality of life.3 With the development of new 
measures for assessing sexual function and new medications for the treatment of ED, effective 
management of sexual problems is now possible. 
BPH is a common medical condition in middle-aged and elderly men worldwide. Because ED 
also has a high prevalence in elderly men, many groups have assessed whether any causal 
relationship between BPH and sexual function exists.2, 4 - 7 Some evidence supports the theory 
that BPH and ED are simply coexisting, age related conditions in aging men that are linked by 
several of the metabolic and hormonal changes that usually affect such men without 
significant correlation between the prostate size, lower urinary tract symptoms (LUTS) and 
ED.4 On the other hand, a few recent reports show a direct correlation between the two 
diseases even after controlling for age, medications and concomitant comorbidities. 2, 5-7 
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Transurethral resection of the prostate (TURP) has been considered the standard surgical 
therapy for lower urinary tract symptoms secondary to benign prostatic enlargement (BPE). 8 
Its high success rate is reflected by substantial improvements in symptom scores, urinary flow 
rate, post-void residual urine (PVRU) and a low retreatment rate on long-term follow-up. This 
has become the yard stick to compare the outcome of newly introduced minimally invasive 
trans-urethral procedures.  
The effect of TURP on sexual function is uncertain and available evidence is conflicting.   As 
detected in the multicenter American Urological Association Cooperative Study, based on 
1,000 men with adequate data available the rate of postoperative ED was 13%.8 In contrast, 
results in a recent report of Leliefeld et al showed no association between BPH treatment and 
postoperative sexual dysfunction. 
In a study examining patients’ own evaluation of sexual dysfunction after TURP, 54% of the 
responders claimed deterioration and half blamed the operation, but the actual rate was less as 
confirmed by more objective reports.10 
The results are variable, the older studies could possibly be an over estimation, possibly 
because of the use of different instruments for assessment, good number of them were not 
standardized tools to assess erectile function, and also because most of these were 
retrospective assessments of erectile function & on many a occasions without pre-TURP 
assessment of sexual function. The availability of standardized, reliable, self-assessment 
questionnaires has made a significant impact on the outlook of assessment of erectile and 
overall sexual function in the setting of clinical trials. 
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Aims of the study 
Aim: To study the effect of Transurethral resection of prostate (TURP) on sexual function 
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Review of Literature 
Anatomy pertinent to penile erection & TURP is reviewed.  
NEUROANATOMY OF PENILE FUNCTION 
Anatomy of the innervation of penis for erection in humans was first reported by Muller in 
1836.11 Innervation of penis is both autonomic (sympathetic & parasympathetic) and somatic 
(sensory & motor).   
Parasympathetic preganglionic input originates in the sacral (S2– S4) spinal cord.12   S3 is the 
main source of erectogenic fibers. The preganglionic fibers from the sacral roots form the 
pelvic nerves (pelvic splanchnic nerves or nervi erigentes) and are joined by fibers from the 
inferior hypogastric nerves (sympathetic) to form the pelvic plexus13 (31), (syn inferior 
hypogastric plexus). The nerves run in the pelvic fascia on the lateral side of the rectum, 
seminal vesicles, prostate, and posterior bladder. 
 The sympathetic preganglionic fibers to the penis arise from the upper lumbar and lower 
thoracic segments of the spinal cord (T10–L2). The fibers pass through the corresponding 
chain ganglia, to synapse in the ganglia of the superior hypogastric plexus, or the presacral 
nerve. This nerve subsequently divides into left and right hypogastric nerves, descending to 
the inferior hypogastric, or pelvic plexus. The hypogastric nerves contain postganglionic 
sympathetic fibers. 
The somatosensory pathway originates at the sensory receptors in the penile skin, glans, and 
urethra and within the corpus cavernosum. The nerve fibers from the receptors converge to 
form bundles of the dorsal nerve of the penis, which joins other nerves to become the 
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pudendal nerve. It enters the spinal cord through the S2-S4 roots to terminate on spinal 
neurons and interneurons in the central gray region of the lumbosacral segment.14  
Activation of these sensory neurons sends messages of pain, temperature, and touch by means 
of spinothalamic and spinoreticular pathways to the thalamus and sensory cortex for sensory 
perception. 
Onuf's nucleus in the 2nd to 4th sacral spinal segments is the center of somatomotor penile 
innervation. These nerves travel in the sacral nerves to the pudendal nerve to innervate the 
ischiocavernosus and bulbocavernosus muscles. Contraction of the ischiocavernosus muscles 
produces the rigid-erection phase. Rhythmic contraction of the bulbocavernosus muscle is 
necessary for ejaculation. 
Anatomy of the cavernous nerve in humans was first reported by Muller in 1836.11  
The cavernous nerve is a branch of the pelvic plexus with parasympathetic and sympathetic 
postganglionic fibers and innervates the penis. The cavernous nerve runs with branches of the 
prostatovesical artery and veins as part of the neurovascular bundle of the prostate. After 
passing the tip of the seminal vesicle and the nerves within the leaves of the lateral endopelvic 
fascia near its juncture with Denonvilliers’ fascia, the cavernous nerve travels at the 
posterolateral border of the prostate and on the surface of the rectum. Passing posterolaterally 
to the prostate, the bundle emits fine branches to supply the prostatic capsule. At the prostatic 
apex, the nerve passes very near to the urethral lumen at the 3 and 9 o’clock positions and 
enters the penile crura more anteriorly, at 1 and 11 o’clock. The cavernous nerves represent 
the final pathway for vasodilator and vasoconstrictor neural input to the cavernous smooth 
muscles.12 
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Stimulation of the pelvic plexus and the cavernous nerves induces erection, whereas 
stimulation of the sympathetic trunk causes detumescence. For rigid-erection production in 
normal men, cerebral impulses travel as follows: through the sympathetic pathway, inhibiting 
norepinephrine release; through the parasympathetic, releasing NO and acetylcholine; and 
through the somatic, releasing acetylcholine. 
It leaves the pelvis between the transverse perineal muscles and the membranous urethra, 
passing below the arch of the pubic bone to supply each corpus cavernosum. The cavernous 
nerve divides into two branches. 
The lesser cavernous nerve, supplies the erectile tissue of the corpus spongiosum and 
the penile urethra.  
The outer, greater cavernous nerve remains beneath the prostatic venous plexus and 
enters the corpora cavernosa around the cavernous vessels in the hilum of the penis. 
Human cadaveric dissection has revealed medial and lateral branches of the cavernous nerves 
(the former accompanying the urethra and the latter piercing the urogenital diaphragm 4 to 7 
mm lateral to the sphincter) and multiple communications between the cavernous and dorsal 
nerves.15 
Parasympathetic efferent stimulates secretion in men from the bulbo-urethral and Littre’s 
glands as well as from the seminal vesicles and prostate.16 
The process of ejaculation involves two steps: emission and ejaculation proper. Emission 
consists of the deposition of secretions from the peri-urethral glands, seminal vesicles, and 
prostate as well as sperm from the vas deferens into the posterior urethra. The accumulation of 
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this fluid precedes ejaculation proper by 1 to 2 s and provides the sensation of ejaculatory 
inevitability. Emission is under sympathetic control from the presacral and hypogastric nerves 
that originate in the T10–L2 spinal cord levels.16 Ejaculation proper (projectile ejaculation) 
involves sympathetic outflow regulated closure of the bladder neck, the opening of the 
external urethral sphincter, and contraction of the bulbo-urethral muscles for propulsion of the 
ejaculate. These are striated muscles innervated by somatic fibers carried in the pudendal 
nerve. Orgasm can occur despite damage to the sympathetic ganglia; however, it is rarely 
possible after injury to the pudendal nerve. 
 
Adapted from P Milhoua, D Lowe & A Melman:  Male sexual function, Normal anatomy & 
physiology. Second edition, pg 12, Humana press, New Jersey 2006. 
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Muller emphasized multiple nerve filaments running from the hypogastric or pelvic plexus to 
the prostatic plexus situated posterolaterally at the base of the prostate, and then coursing 
posterolaterally along the prostate to the cavernous plexus at the base of penis. In Muller’s 
original thesis, the periprostatic plexus-like anatomy of the cavernous nerve was clearly 
described. Muller distinguished a major and several minor cavernous nerves.11 
Walsh helped revolutionize radical prostatectomy by defining the neurovascular bundle 
(NVB) that can be preserved in appropriate patients. The nerve-sparing procedure was initially 
described by Walsh on the basis of the traditional concept that the nerve fibers responsible for 
erectile function run exclusively in the neurovascular bundle (NVB) on the postero-lateral 
aspect of the prostate. 
The recent micro-anatomical studies have also indicated a significant amount of nerve fibers 
along the ventral circumference of the prostatic capsule, forming a periprostatic nerve 
network. By using electro-physiologic testing, the present study indicates that periprostatic 
nerve fibers along the anterior and lateral circumference of the prostatic capsule also 
contribute to erectile function, along with nerve fibers in the NVB at the posterolateral 
circumference of the prostate.  
The traditional concept that the nerve fibers responsible for erection run exclusively in the 
NVB has thus been replaced by the recent concept of the periprostatic nerve network. 18,19 
Lunacek et al described the changing course of cavernosal nerves during fetal development 
and the growth of the prostate with benign prostatic hypertrophy (BPH) in an extensive 
histologic study of 29 fetal and 8 adult male specimens. They found that the cavernosal 
nerves, which run downward laterally and dorsally during early gestation, became displaced 
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further laterally and anteriorly along the convex surface of the prostate with the growth and 
increasing volume of the prostate after gestational week.11  
Epidemiology 
ED or impotence is defined as ‘‘the inability of the male to achieve an erect penis as part of 
the overall multifaceted process of male sexual function.’’ 
The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition–Text Revision 
(DSM-IVTR), diagnostic criterion set for Male Erectile Disorder 
A. There is a persistent or recurrent inability to attain or to maintain until completion of the 
sexual activity an adequate erection. 
B. The disturbance causes marked distress or interpersonal difficulty. 
Classification, Etiology & Risk factors for ED 
Erectile dysfunction can be classified based on the etiology (diabetic, iatrogenic, traumatic), or 
on the neurovascular mechanism (failure to initiate [neurogenic], failure to fill [arterial], and 
failure to store [venous].   
Risk factors 
Common risk factors associated with sexual dysfunction include age, the general health status, 
diabetes mellitus, cardiovascular disease, concurrence of genitourinary disease, psychiatric or 
psychologic disorders, other chronic diseases, and socio-demographic conditions. 
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Etio-pathogenesis 
These factors in isolation or together can cause erectile dysfunction. The etio-pathogenesis is 
depicted in this schematic diagram. 
 
Adapted from TOM F. LUE, Campbell-Walsh Urology, 9th ed Chapter 21 – Physiology of 
Penile Erection and Pathophysiology of Erectile Dysfunction  Saunders 2007 
Importantly, it has not been determined how much the two conditions LUTS & ED influence 
each other and whether the normal aging process can be considered the main factor in the 
pathophysiology of both ED and LUTS. 
Many tentative theories have been proposed to explain the association between ED and LUTS, 
as the ‘‘common-theme’’ hypothesis. Organic or psychogenic factors could be the 
mechanisms for ED in men with LUTS.20, 21  
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Four leading possible mechanisms of how these diseases LUTS & ED interrelate were 
suggested, e.g. the nitric oxide synthase/nitric oxide theory,23 autonomic hyperactivity effects 
on LUTS and ED24, increased Rho kinase activation/downregulation of endothelin-B receptor 
sites25 and prostate and penile artherosclerosis.26 Anatomic factors due to the enlarged prostate 
were proposed to have advert effects on erectile function.27 
Important ED risk factors, such as diabetes and ischemic heart disease (IHD) also negatively 
affect the penile vascular status.28, 29 However, the association between vascular abnormalities 
and both ED and LUTS has not been confirmed. 
Possible common components linking LUTS / BPH, ED & EjD 
Possible links LUTS / BPH ED EjD 
↑ α - adrenergic activity    
Alteration in α1 –adrenergic receptor subtypes    
↓ NO bioactivity (endothelial dysfunction)   ? 
Testosterone / estrogen imbalance    
5 – HT ?   
Age-related changes in circulating hormone levels and an imbalance in the testosterone / 
estrogen ratio may play a role in the pathophysiology of BPH and sexual dysfunction. 
Longitudinal data from the MMAS indicated that serum levels of total testosterone, 
dehydroepiandrosterone (DHEA), DHEA-sulfate, cortisol, and estrone declined, whereas 
levels of DHT, sex hormone binding globulin, luteinizing hormone, follicle-stimulating 
hormone, and prolactin increased in men who were aged 40 to 70 years at baseline and 
followed for 7 to 10 years.30 
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Proposed theory of autonomic hyperactivity of LUTS & ED. Increased autonomic activity 
resulting from BMI, hyperinsulinemia, increased age & decreased physical activity effects 
BPH growth, LUTS & vasomotor forces that result in ED.24 
Risk factors have been evaluated for their relative risk of causing ED in this study by krimpen 
study by blanker31. 
Risk factors Relative risk 
Age (55–78) 2.3–14.3 
BMI >30 3.0 
LUTS 1.8–7.5 
Cardiac Surgery 2.5 
COPD 1.9 
Smoking 1.6 
The large variation in LUTS related Ed risk relates to the severity of the IPSS score  
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Age is one of the most important risk factors for ED. Compared to men in their 5th decade 
men in their 6th decade have a 2-fold increase in their relative risk (RR) of ED. The RR 
increases to 5-fold for men in their 60s.30, 31 
Worldwide the prevalence of ED, studies conducted between 1993 and 2003, stratified by age 
showed a rising prevalence of ED. Between the ages of 40 and 70 years, the probability of 
complete ED increased from 5.1% to 15%, moderate dysfunction increased from 17% to 34%, 
and mild dysfunction remained constant at about 17%. Before age 40 the rate was 1% to 9%; 
from 40 to 59 it ranged from 2% to 9% to as high as 20% to 30%. 
Studies from other countries had noticed that the prevalence of erectile dysfunction increases 
with age, which was noted as early as the 1940s. Two studies on the prevalence of ED in the 
general population are-  
1. Massachusetts Male Aging Study (MMAS) and  
2. National Health and Social Life Survey (NHSLS).  
General population studies Data from the National Health and Social Life Survey (NHSLS), a 
population-based representative sample of US adults aged 18 to 59 years, demonstrated a high 
prevalence of sexual dysfunction in men (31%) and women (43%).28 A study of 2476 Spanish 
men aged 25 to 70 years indicated that the prevalence of ED was 12% to 19%, with the rate 
dependent on the self-administered questionnaire used to assess sexual function.29 The results 
of the NHSLS indicated that LUTS was a significant predictor for ED.  
MMAS was the first large-scale, community-based study on ED in non-institutionalized 40 to 
70-year-old men in the Boston area. Amongst the total of 1290 men aged 40–70 years 52% of 
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men reporting some degree of erectile dysfunction—mild in 17.1%, moderate in 25.2% and 
complete in 9.6s. %.  The prevalence of complete ED was age-dependent, increasing from 5% 
for men aged 40 years to 15% for those aged 70 years2.  
LUTS & Erectile dysfunction 
Lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH) and 
sexual dysfunction (SD) are highly prevalent in men over the age of 50.34 
The prevalence of ED and LUTS in older men may be as high as 52% and 32% respectively. 
Community-based studies underlined that sexual satisfaction negatively correlates with 
increasing age and LUTS.20  
Several recent analyses1, 2, 20- 22, 32  strongly suggest that although age is an independent risk 
factor for both LUTS and SD, LUTS is also an independent risk factor for SD.  
Treatment of LUTS and BPH which includes pharmacologic, minimally invasive, and surgical 
therapies could also have an impact on sexual function. 
The Multinational Survey of the Aging Male (MSAM-7) is the most comprehensive study 
conducted to date on the association of age, LUTS, concomitant comorbidities, and male 
sexual dysfunction (both ED and EjD). It is a large-scale, multinational survey of 
approximately 14,000 men 50 to 80 years old from United States and 6 European countries.2 
The results of this study confirmed the relationship between LUTS and sexual dysfunction in 
men, independent of the effects of age, other comorbidities, and lifestyle. The overall 
prevalence of ED in the MSAM-7 was 49%, with 10% reporting complete absence of 
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erections. The prevalence of ED was age-dependent, with rates of 31%, 55%, and 76% in men 
aged 50 to 59 years, 60 to 69 years, and 70 to 80 years, respectively. 
The MSAM-7 study revealed a strong association between the level of sexual activity and 
IIEF score with patients’ IPSS score.2 The association between LUTS and ED persisted, even 
when controlled for age and other co-morbidities, that are known to impact sexual function. 
Other measures of ejaculatory dysfunction, reduced ejaculate and ejaculation pain also 
strongly associated with LUTS.  
Importantly, the overall prevalence of EjD (defined as ejaculation with decreased amount of 
semen or loss of ejaculation) in men able to achieve erections was 46%, with 5% of the men 
reporting complete absence of ejaculation. 
As was observed with ED, the prevalence of EjD was age dependent, with rates of 29%, 55%, 
and 74% in men aged 50 to 59 years, 60 to 69 years, and 70 to 80 years, respectively. Both ED 
and EjD were also significantly associated with the severity of LUTS (p < 0.001). Age and 
LUTS were stronger risk factors for ED and EjD than was diabetes, hypertension, heart 
disease, or hyperlipidemia. 
A cross-sectional community-based survey investigated the possible role between sexual 
function and LUTS noted that sexual satisfaction negatively correlated with increasing age 
and LUTS. The relative risk of ED stratified by International Prostate Symptom Score (IPSS) 
ranged from a relative risk 1.0 at IPSS 0 to a 3.3 fold increase in relative risk for IPSS greater 
than 19. 21 
In the Cologne Male Survey of approximately 5000 German men aged 30 to 80 years, the 
overall prevalence of ED was 19%, with a significant association between ED and LUTS, 
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hypertension, diabetes, and pelvic surgery.1 The prevalence of LUTS was 72% in men with 
ED versus 38% in those without ED. An additional analysis of the Cologne Male Survey data 
used multifactorial methods to show that, in addition to age, diabetes, hypertension, and pelvic 
surgery, LUTS is an independent risk factor for ED.6 
The multinational UrEpik study performed in regions of the UK, the Netherlands, France and 
Korea demonstrated an unequivocal association between ED and LUTS (p < 0.001). It 
investigated the relationship between LUTS and sexual dysfunction in 4800 men aged 40 to 
79 years.35 The overall prevalence of ED was 21%, which was significantly associated with 
increasing age (p < 0.001). After adjusting for age and country, men with diabetes, 
hypertension, or LUTS had a greater risk of ED. 
Similarly, the Krimpen study of sexual dysfunction assessed the relative risk (RR) for ED in a 
community cohort.31 In this important study, LUTS had a strong relationship with increasing 
risk of ED (dose response curve). The authors noted an increased RR of ED from 1.8 to 7.5 
depending upon the degree of urinary complaints. This increased RR of ED based on the 
severity of LUTS was greater than that found with the more traditional ED risk factors 
(cardiac symptoms, pulmonary problems and a history of smoking. This suggests that ED is a 
worthwhile symptom to question among patients who present with LUTS. 
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Adapted from the Krimpen Study by Blanker et al31  
Based on the possible common pathophysiological mechanisms of LUTS/BPH and sexual 
dysfunction as well as other common comorbidities observed in aging men with these 
conditions, further multidisciplinary studies seem warranted preliminary data have suggested 
that treatment with sildenafil improves LUTS in men with ED, possibly as the result of 
smooth muscle relaxation in the lower urinary tract.36  
Recent data from an open-label study have suggested that treatment with Alfuzosin 10 mg OD 
for 1 year significantly improves ED, EjD (defined as ejaculation with decreased amount of 
semen or loss of ejaculation), and pain/discomfort during ejaculation in men with LUTS 
associated with BPH.37 
In 2 randomized, double-blind, placebo-controlled studies in men with BPH, treatment for 13 
week with Doxazosin, which was titrated to 8 mg OD, resulted in significant improvements 
from baseline for those patients who had sexual dysfunction to start with.38 Furthermore, in an 
observational study of men with BPH, treatment with Doxazosin for 1 month resulted in a 
significant improvement in sexual function compared with that at baseline, especially for 
those with moderate-to-severe ED at baseline.39  
TURP & Erectile dysfunction         
TURP is the reference standard in the surgical treatment for BPH8. The question of whether 
and to what degree a transurethral resection of the prostate (TURP) has an influence on sexual 
function has been widely evaluated. Its influence on the sexual function is uncertain and the 
available data is conflicting.  
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The impotency seen immediately after TURP may be temporary. A study in potent men using 
the snap-gauge test 4 days and 3 months after TURP showed a high impotency rate in the 
immediate postoperative period which significantly improved at retesting.40 Neuropraxia from 
thermal injury or the emotional stress of surgery have been proposed as possible 
mechanisms.41 It is important to note, however, that a good number of these studies were 
retrospective and that a preoperative examination of erectile function was not performed. The 
high percentage of postoperative retrograde ejaculation is viewed as a negative influence on 
sexuality. Often, it is difficult for patients to differentiate between ejaculatory and erectile 
dysfunction. 
Etiology  
The etiology of erectile dysfunction following TURP has not yet been established. It may be 
associated with age or a preexisting dyserection.42 
Psychological changes following TURP or a loss of antegrade ejaculation can impair erectile 
function43, 44 but a genuine organic erectile dysfunction may certainly be encountered. Various 
hypotheses have been advocated, including cavernous nerve injury, fibrosis or thrombosis of 
the cavernous arteries, fibrosis of the corpora cavernosa and venous leakage.40 
The exact mechanism of small nerve fiber damage during TURP remains undetermined. 
Capsular perforation is known to be a risk factor for impaired post-operative erectile 
function.43 This could be due to a direct injury of the cavernous nerves that run at a few 
millimeters from the prostatic capsule, inflammation due to extravasation of irrigation fluid or 
that of mechanical stress.45. 
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Theoretically, during TURP the HF-generated current close to the capsule may damage the 
neurovascular bundles. This could happen if the gland is resected beyond the capsule entering 
the venous sinus with efforts to control bleeding in that area. The rate of impotence varies 
from 3.4 to 32% in the literature 46, 47 However, there are also reports of improved erections 
after TURP.48  
a. TURP & worsening erectile function 
Surgical interventions for LUTS/BPH, such as TURP, have been reported to cause ED and 
EjD (particularly retrograde ejaculation). The estimated incidence of ED in a meta-analysis 
was 10% in 15 trials (versus 2% for sham control) and the estimated incidence of EjD was 
65% in 19 trials (versus 2% for sham control) that had TURP as the control arm.49 
In a multicenter American Urological Association Cooperative Study, based on 1,000 men the 
rate of postoperative ED was 13%8. In a prospective study with over 500 subjects undergoing 
TURP, the incidence of  erectile dysfunction following TURP as assessed by IIEF-5 
questionnaire  was noted to be 12% and presence of diabetes mellitus and observed intra-
operative capsular perforation were the risk factors identified associated with occurrence of 
erectile dysfunction50.  
A study from 1987 showed a postoperative impotence rate of approximately 30% at 1 month 
following TURP.51  In the follow-up this high rate fortunately decreased to approximately 
20%, and it was thought to be a frequent side effect of the operation.52, 53 It is important to 
note, however, that all studies were retrospective and that a preoperative examination of 
erectile function was not performed. The high percentage of postoperative retrograde 
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ejaculation is viewed as a negative influence on sexuality. Often, it is difficult for patients to 
differentiate between ejaculatory and erectile dysfunction. 
Using a the Snap-Gauge test in 98 patients who underwent TURP it was estimated that 
Transurethral resection of the prostate has an overall risk of 8.3% of damage to erectile 
potency, which appears to be greater (11.1%) only if a patient older than 65 years has a 
prostatic adenoma with 10 gm. of resectable tissue40. Tscholl et al. reported that a small size of 
an adenoma was a risk factor for post-operative erectile dysfunction probably because of 
higher risks of capsular perforation. Conversely, in case of large adenoma, the cavernous 
nerves are more protected because of their distance from the site of the resection.   
The data collected by Tscholl et al. implies the fact that this disturbance might be only 
temporary. In repeated postoperative ‘‘Snap-Gauge Studies’’ the majority (31/34; _81.7%) of 
patients who originally showed an objective impotence after surgery experienced an 
improvement in potency after three months. The reasons for this phenomenon are not yet 
known.   
In a study of 83 preoperative potent men it was shown that postoperative impotence seemed to 
be caused by a capsular perforation in the region of the nerve bundles, especially in small 
prostates.43 Other authors, however, believe that a venous occlusion syndrome of the dorsal 
prostatic vein plexus is responsible for postoperative impotence following TURP.45  
b. TURP & improved erectile function  
VA Cooperative Study compared the outcomes of TURP and watchful waiting in 556 men 
with moderate LUTS48. In this study by Wasson et al symptomatic BPH patients were 
randomized either in a TURP group or a watchful-waiting group.  TURP was not associated 
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with changes in general well-being, social activities, or sexual performance (P=0.92). At the 
end of the 3-year study, 19% of patients in the surgery group and 21% of those in the watchful 
waiting group reported that their sexual performance was worse, while 3% in each group 
reported it was improved suggesting worsening of baseline erectile function with untreated 
LUTS, and that surgical treatment would improve erectile function. Furthermore, men who 
had TURP were significantly less likely to have pain during ejaculation than those who had 
laser therapy or watchful waiting.  
The results of this study indicate the spouses or partners thought that the patients’ sexual 
performance was unaffected over the course of the study and  that TURP has a more 
beneficial effect on certain aspects of sexual function (i.e., erectile function and pain during 
ejaculation) than is with watchful waiting. 
A recent randomized, controlled trial evaluated ED and EjD (decreased amount of semen with 
ejaculation, loss of ejaculation, and pain/ discomfort during ejaculation) at baseline and 6 to 
12 months after TURP, non-contact laser therapy, or watchful waiting in 340 men aged 48 to 
90 year with LUTS/BPH.  
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TURP- transurethral resection of prostate WW – watchful waiting 
LT – Laser therapy Ej pain- ejaculatory pain 
A significant decrease from baseline in the percentage of men with ED & a significant 
reduction in the percentage of men with pain during ejaculation were demonstrated after 
TURP, when compared to Laser prostatectomy or watchful waiting. 54 
A prospective randomized trial in 2003 compared erectile dysfunction following TURP done 
with standard monopolar power in group 1 and done with Laser in group 2, followed up to 2 
years postoperatively55. There was a marginal, insignificant improvement in the erectile 
function but no difference in the 2 groups. Prevalence of erectile dysfunction decreased from 
preoperative values of 53.3% and 51.6% to 51.6 % and 48.3% in groups 1 and 2, respectively. 
Significant deterioration in the mean IIEF orgasmic function and ejaculatory function domain 
scores postoperatively was reported with similar incidence in the 2 groups. A positive linear 
correlation was found between mean I-PSS, QOL and IIEF-EF domain score improvement 
after surgery, suggesting postoperative urinary symptoms and QOL amelioration on patient 
erectile function. 
The cessation of preoperative medications, such as finasteride and α-blockers, might 
potentially have contributed to the reported slight postoperative improvement in sexual 
function.  
 
26 
 
c. Stable sexual function following TURP 
There are studies noticing no change of erectile function following TURP. 
Long-Term Effects on Sexual and Urinary Function and Quality of Life was studied by C. 
Deliveliotis et al in patients undergoing TURP.  The sexual function was compared with an 
age-matched control population. 98 patients who underwent TURP for BPH were compared 
with a group of 80 apparently healthy men56. 
The general quality of life was estimated by the Rand 36-Item Health Survey 1.0. Urinary 
function was estimated by the AUA Symptom Index and the UCLA Prostate Cancer Index 
(urinary function and bother scale). Sexual function and bother, were explored using the Brief 
Male Sexual Function Inventory (MSFI) for Urology. Patient outcome 2 years post treatment 
was compared to the pre-treatment status and to that of the matched control population. 
General quality of life was not affected by TURP. TURP, as was expected, restored urinary 
function and bother to normal population norms. Elderly males had urinary function and 
bother similar to the operated patients. TURP marginally affects sexual life, mainly due to the 
loss of ejaculation, while in men from the control group, sexual function, although affected, 
was still present.  
 
A recent report by H Leliefeld and colleagues9 confirms the idea that the relation is 
coincidental. Prospectively, these investigators examined patients at baseline and 9 months 
after various treatments for BPH with questionnaires on voiding symptoms, related 
complications, and sexual function. 84% of patients reported no change in sexual function. All 
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modes of treatments showed both improvement and deterioration in 3–14% and 0–16% of 
patients, respectively.  
In a prospective RCT by F MONTORSI et al 100 patients were randomized to TURP & 
HoLEP57.  Erectile function of all patients was evaluated with IIEF, pre-operatively & at 1 yr 
post-operatively. Mean erectile function scores pre-operatively were 22.3 & 21.4 in the 
HoLEP & TURP groups, respectively. At 1 yr scores were 23.8 & 24.1 in HoLEP & TURP 
groups, respectively, with no statistically significant difference among them. This suggests a 
stable erectile function was maintained following TURP as well as HoLEP.  There was no 
significant change in sexual desire, intercourse satisfaction & overall satisfaction in both the 
groups.  
A total of 204 patients with bladder outflow obstruction (BOO) secondary to BPH were 
prospectively randomised 1:1 into either the PKEP group or the TURP group. IIEF scores 
were assessed pre-operatively and on follow up to 3 years.  38.2% patients in the Bipolar 
TURP group and 42.2% monopolar TURP group had potency sufficient for intercourse & 
were sexually active. Erectile function as assessed by IIEF scores, overall was, 19.4 +/- 5.1 
(range 7–25), that in the saline TURP group was 19.3 +/- 4.6 (range 7–25) & in the TURP 
group was 19.6 +/- 4.8 (range 7–25). This was not significant different. Post-operatively the 
mean scores of erectile function in IIEF were 20.2 with saline TURP & 20.8 in the monopolar 
TURP group. Neither bipolar TURP nor TURP caused significant changes in erectile potency 
postoperatively58.  
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The question of whether, and how often does TURP result in erectile dysfunction, cannot be 
answered conclusively by the current literature. 
In any case, currently from the available literature pertaining to erectile function following 
TURP it is imperative to considered the following points, 
1. pre-TURP patient education and clarification,  
2. pre- and post TURP objective evaluation of erectile function, 
3. strict indication for surgery in younger patients, 
4. in potent, sexually active patients with a small prostate, a careful resection of the prostate in 
the area of the neurovascular bundle, 
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Materials & methods 
All patients undergoing TURP for Benign prostatic hyperplasia were included in the study. 
Data was collected preoperatively with a detailed sexual history and evaluation regarding 
sexual dysfunction, which included IIEF questionnaire. Independent risk factors for erectile 
dysfunction were noted as in severity of LUTS using I-PSS, age of the patient & medical co-
morbid conditions. Intra-operative findings were noted regarding duration of the procedure, 
amount of gland resected. The sexual function of the patients was evaluated by the IIEF 
questionnaire at 3 months postoperatively. 
Data was analyzed for any change in the erectile function. 
Setting: The study was conducted in the Department of Urology, CMC Hospital. The study 
spanned 1 year commencing March 2010. Recruitment was done for 9 months from March 
2010 to November 2010 and the follow up was for 3 months from surgery. 
Inclusion  
All patients undergoing TURP for BPH who were sexually active were included in the study.  
Exclusion 
Patients with psychiatric disease, who have been treated for impotence, had prior TURP or 
other minimally invasive surgery for BPH or pelvic trauma or surgery, and those with 
carcinoma prostate diagnosed postoperatively on histopathology examination were excluded 
from the study. 
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 Variables:  
Primary outcome of this study was to assess erectile function following TURP done for BPH 
The exposure was the surgery, namely transurethral resection of prostate (TURP).  
Erectile function of the subject was assessed, as per IIEF questionnaire that was answered by 
the subject.   
C) Primary outcome was the change in the erectile function that was assessed based on the 
IIEF (International Index of Erectile Function) questionnaire evaluating 5 domains of the male 
sexual function. 
Scoring Algorithm for IIEF: All items are scored in 5 domains as follows: 
Domain   Question  numbers      Range Score      Max Score 
Erectile Function   1, 2, 3, 4, 5, 15     0-5      30 
Orgasmic Function  9, 10      0-5      10 
Sexual Desire    11, 12     0-5      10 
Intercourse Satisfaction 6, 7, 8      0-5      15 
Overall Satisfaction  13, 14      0-5      10 
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The severity of ED was further classified into the following 5 categories: no ED (EF score, 
26-30), mild (EF score, 22- 25), mild to moderate (EF score, 17-21), moderate (EF score, 11-
16), and severe (EF score, 6-10). 
Erectile function scores were compared before and after surgery. 
The International Index of Erectile Function is a multidimensional, self-administered 
questionnaire for the clinical assessment of ED. This validated questionnaire has been shown 
to discriminate between men with and without ED. The erectile function (EF) domain of the 
questionnaire has also been shown to provide a reliable measure for classifying the severity of 
ED.  
The International Index of Erectile Function was self-administered to each patient in their 
language. The 6 items on the EF domain included questions concerning erection frequency, 
firmness, penetration, maintenance frequency, maintenance ability, and erection confidence 
during the last 4 weeks. Each item was based on a 5-point Likert scale, and the responses to 
all 6 items were summed to arrive at a total EF score ranging from 1 to 30. Men who had 
made no attempt at sexual activity in the past 4 weeks were not included in the present 
analysis, which was restricted to those individuals with a total score of 6 or more. A higher 
score indicated relatively better EF. Previous evaluation of the EF domain had determined an 
optimal cutoff score of less than 26 for those having ED. 
a. Data Sources/measurement:  
Data regarding sexual function was collected by the primary investigator preoperatively and at 
3 months postoperatively using IIEF questionnaire.  
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Sample size calculation 
The proportion expected to undergo change in the status of erectile function 10% and a 
precision of statistical analysis to be +/-6% and the confidence interval to be 95%, the sample 
size was calculated to be 107 subjects. 
Statistical methods: This is a prospective cohort study wherein the subjects were their own 
controls. For patients who defaulted at follow up, IIEF questionnaire was collected in person, 
by mail or telephonic interview.    
With the available literature the expected change in the incidence of post-op ED may vary 
from an average of 15% --to—stable erectile function –to a possible improvement in the 
erectile function.  
Erectile function was assessed for both normal & dysfunction on the same scale with a scoring 
system, scores ranging from 0- 30. Pre & post TURP statistical analysis was done with a 
paired t- test. 
 
 
 
 
34 
 
 
 
 
 
 
 
 
 
 
RESULTS 
35 
 
Results 
A total of 107 who underwent TURP and were sexually active were included in the study. The 
mean patient age was 61.3 yr (range: 48 to 70 yr). Baseline features of these patients are as 
shown in the table below 
Baseline parameters (mean) Values (range) 
Age (yr) 61.3  (48 – 70) 
Mean AUA symptom score 16.1 (8 – 33) 
IIEF score mean 52.07 (24 – 74) 
Erectile function score mean 21.6    (7 -30) 
Orgasm & ejaculatory function score, mean 7.94    (3 – 10) 
Serum creatinine, mg% 1.2   ( 0.8 – 2.5) 
Prostate size  mean, gm 31.6   (20 – 50) 
Effect of LUTS on erectile function as noted in literature is difficult to apply to this study 
group as the study group was not all LUTS patients but those with an indication for TURP and 
hence mean AUA symptom scores of the group can be expected to be higher. Mean AUA 
symptom score of these patients was 16.1.                 
Sexual function, as assessed by IIEF scores, showed a mean value of 52.07 and the erectile 
function mean score was 21.6. Pre-Categorization of erectile function showed the following 
distribution pattern. 
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Erectile Function score categories (score over 30) Number (n= 107) 
No ED                             (26-30) 24 
Mild ED                          (22-25) 37 
Mild-moderate ED      (17-21) 31 
Moderate ED                (11-16) 9 
Severe ED                      (6-10) 6 
Mean erectile function scores were noted to be different in 2 age groups less than or more than 
65 yr of age. 
 Entire group 
Upto age 65 yr 
(n=78) 
Above 65 yr 
(n= 29) difference 
Significance 
(p value) 
IIEF score, 
mean 52.0748 53.87 46.93 6.94 0.018 
EF scores 21.4206 22.5 18.2 4.3 0.02 
In the age group of more than 65 yr the overall IIEF scores & erectile function scores were 
less than in patients with age up to 65 yr which was statistically significant. 
Of the 107 study patients 22% had normal erectile function, 9 had moderate with 6 having 
severe erectile dysfunction. Most common occurrence of erectile function was seen in mild or 
mild to moderate ED category with 68 patients, nearly 2/3rd of total.  
Data was analyzed for the effect of age on sexual function in patients with benign prostatic 
enlargement with LUTS in whom TURP is indicated. 
The grade of erectile dysfunction varied with age. 
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Cross-tabulation of categories of erectile function groups in the 2 age groups 
 
 
ED categories 
Total
No ED Mild ED Mild-mod ED Moderate ED Severe ED 
AGE 
≤65 yr 20   (25.6%) 31  (39.7%) 23 (29.5%) 2   (2.6%) 2    (2.6%) 78 
>65 yr 4   (13.8%) 6  (20.7%) 8 (27.6%) 7  (24.1%) 4  (13.8%) 29 
Total 24  (22.4%) 37  (34.6%) 31 (29.0%) 9    (8.4%) 6    (5.6%) 107 
 
Based on cross-tabulation of categories of the baseline erectile function scores, it was noticed 
that in age group up to 65 yr 95% of patients has up to mild-moderate ED, only 5.2 % had 
moderate to severe ED. In patients with age more than 65 yr 37.9% had moderate to severe 
ED prior to TURP.    
 Among patients with moderate & severe LUTS 70% were aged more than 65 yr. 
Following TURP IIEF scores at 3 months were collected. Pre-TURP & Post-TURP data are 
tabulated as below and Paired t- test analysis of these groups was done. 
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Paired Samples Test 
 
1-Pre-TURP 
2-Post TURP 
Paired Differences 
t df Significance
Mean Std. Deviation
Std. 
Error 
Mean
95% Confidence Interval 
of the Difference 
Lower Upper 
 IPSS 1 – 2 15.7500 5.57249 .56874 14.6209 16.8791 27.693 95 .000 
 QOL 1 – 2 2.9720 1.03211 .09978 2.7741 3.1698 29.786 106 .000 
 IIEF 1 – 2 2.9252 4.77158 .46129 2.0107 3.8398 6.341 106 .000 
 Erectile function 1 – 2 .6262 2.31290 .22360 .1829 1.0695 2.800 106 .006 
 Intercourse satisfaction     1 – 2 -.0935 1.25542 .12137 -.3341 .1472 -.770 106 .443 
 
Orgasm 
ejaculation 
Function 1 – 2 
2.1776 1.46541 .14167 1.8967 2.4584 15.371 106 .000 
 Desire 1 – 2 .0748 1.11339 .10764 -.1386 .2882 .695 106 .489 
 Overall satisfaction 1 – 2 .0093 .87411 .08450 -.1582 .1769 .111 106 .912 
After statistical analysis with paired t-test, the IPSS scores & QOL scores, as would be 
expected, improved significantly following TURP.  Different aspects of sexual function as 
assessed by IIEF questionnaire, comparing Pre- & Post-TURP, showed that there was a 
decrease of ejaculatory & orgasmic function scores which has been well documented in the 
past. The sexual desire, intercourse satisfaction & overall satisfaction aspects of sexual 
function did not show any significant change following TURP.  
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However, erectile function & overall IIEF score scores decreased following TURP which 
attained statistical significance, as depicted below. A change in the overall IIEF scores is less 
meaningful than EF scores, in the context of the current study.  
107107N =
EF2Erectile function Q
40
30
20
10
0
107
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For descriptive statistics, to analyze the effect of age on erectile function, the study group was 
divided into 2 groups;  
Group – I: up to age 65 yr (n= 78) &  
Group – II : more than age 65 yr (n= 29).   
 
Pre- TURP Post-TURP
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Group- I : Paired Samples Test  
 
1: Pre-TURP 
2: Post-TURP 
Paired Differences 
t df 
Sig. 
(2-
tailed
) Mean 
 
Std. 
Deviation
Std. 
Error 
Mean
95% Confidence 
Interval of the 
Difference 
Lower Upper 
 IPSS1 - IPSS2 16.4930 5.71932 .67876 15.1392 17.8467 24.299 70 .000 
 QOL1 - QQL2 3.0256 1.04415 .11823 2.7902 3.2611 25.592 77 .000 
 IIEF1 - IIEF2 2.6410 5.18483 .58707 1.4720 3.8100 4.499 77 .000 
 Erectile function 0.4615 2.35042 .26613 -.0684 .9915 1.734 77 .087 
 Intercourse Satisfaction -.1667 1.36198 .15421 -.4737 .1404 -1.081 77 .283 
 
Orgasm 
ejaculation 
Function 
2.2179 1.44732 .16388 1.8916 2.5443 13.534 77 .000 
 Desire .0128 1.13382 .12838 -.2428 .2685 .100 77 .921 
 Overall satisfaction -.0385 .85951 .09732 -.2323 .1553 -.395 77 .694 
 Gland size - Gland resected 14.7662 4.63084 .52773 13.7152 15.8173 27.981 76 .000 
The erectile function scores did not change significantly following TURP, which is depicted 
in the box plot below, in the group 1 with subjects aged less than 65 yr. 
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Erectile function Box plot 
7878N =
EF2Erectile function Q
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On subgroup analysis, in patient up to age 65 yr, n=78, the Erectile function scores did not 
show any statistically significant change in scores following TURP.  
Pre-TURP Post-TURP
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Group –II : Paired Samples Test 
1-Pre-TURP 
2-Post-TURP 
 
Paired Differences 
t df 
Sig. (2-
tailed) p 
value Mean Std. Deviation
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
 IPSS1 -2 13.6400 4.60869 .92174 11.7376 15.5424 14.798 24 .000 
 QOL1 - 2 2.8276 1.00246 .18615 2.4463 3.2089 15.190 28 .000 
 IIEF1 - 2 3.6897 3.38171 .62797 2.4033 4.9760 5.876 28 .000 
 Erectile function EF1 - 2 1.0690 2.18650 .40602 .2373 1.9007 2.633 28 .014 
 Int Sat 1 - 2 .1034 .90019 .16716 -.2390 .4459 .619 28 .541 
 
Orgasm 
ejaculation 
Function 1 -2 
2.0690 1.53369 .28480 1.4856 2.6524 7.265 28 .000 
 Desire 1-2 .2414 1.05746 .19637 -.1609 .6436 1.229 28 .229 
 Overall satisfaction 1-2 .1379 .91512 .16993 -.2102 .4860 .812 28 .424 
 
Gland size- Gland 
resected 15.6552 5.74006 1.06590 13.4718 17.8386 14.687 28 .000 
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In age group more than 65 yr, there was a decrease in mean erectile function scores which 
attained statistical significance. This had affected erectile function scores of the overall group. 
Change in ejaculatory function & its effect on erectile function 
The mean ejaculatory & orgasmic function scores pre & post-TURP were 7.9252 & 5.7477 
respectively. The reduction in the ejaculatory function concurs well with the post-TURP 
association of retrograde ejaculation, which is seen in range of 60-90%. Of the 107 patients 
90.66% (97 subjects) showed worsening of ejaculatory & orgasmic function, 9.34% (10 
subjects) showed an improvement in the same.  
Erectile function scores had remained stable in 71% (76 subjects), in 21.5% (23 subjects) 
deteriorated & in 7.5% (8 subjects) showed an improvement.  
Data was analyzed to know whether, following TURP, the change in ejaculatory function 
scores correlated with the change in erectile function scores. 
In group of stable erectile function, improvement of ejaculatory function scores was seen in 7 
of 76 patients and in the rest 69 ejaculatory function scores worsened, ratio being nearly 1:10. 
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In the group with improved erectile function with 8 subjects, improvement of ejaculatory 
function scores was seen in ration of 1:7 against worsening.  
In the group 23 subjects showing worsened erectile function following TURP, ejaculatory 
function scores improved in 2, keeping the ratio of improved to worsened ejaculatory function 
scores to nearly 1: 10. Following TURP, all 3 groups of erectile function scores showed the 
same pattern of change in ejaculatory function. The ratio of improvement to worsening of 
ejaculatory function scores had proportion of patients in all groups. 
Categories of erectile function 
The change in scores of erectile function categories pre & post TURP was analysed which 
showed a reduction of erectile function scores of the mild ED category. 
 
 
 
          Pre-TURP 
          Post-TURP 
Categories of Erectile function 
0- No ED 
1- Mild ED 
2- Mild-Moderate ED 
3- Moderate ED 
4- Severe ED 
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To compare the change in scores of erectile function categories pre & post TURP, cross-
tabulation of data was done.  
Cross-tabulation  
 
 
Post-TURP 
Total 
No ED Mild Mild-mod Moderate Severe 
Pre-
TURP 
No ED 23 1 24 
Mild 2 18 17 37 
Mild-
Mod  
4 22 5 
 
31 
Moderate 1 1 7 9 
Severe 1 5 6 
Total 25 24 41 12 5 107 
Findings noted on cross-tabulation 
1. Patients with normal erectile function or no ED group maintained stable erectile 
function following TURP. None of them worsened to moderate or severe ED, only one 
patient had mild ED. 
2. None of the patients with moderate ED worsened to severe ED. 
3. One of 6 patients with severe ED & 2 of 9 with Moderate ED had an improved Erectile 
function score following TURP. This was not a statistically significant change as the 
numbers were less for subgroup analysis.  
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4. A deterioration of erectile function was noted in the following patients: 
a.  17 of 37 with mild ED had an Erectile function scores of mild – moderate ED 
post TURP, which was not significant. 
b. Of the 31 with mild-moderate ED, 4 improved to mild ED & 5 deteriorated to 
moderate ED.   
5. 2 of moderate ED & 1 from severe ED improved on their erectile function scores. 
Overall change of erectile function largely occurred in 2 groups with mild ED & mild-
moderate ED, wherein patients had small change in erectile function to next category. There 
was no deterioration of erectile function from any of the categories to severe ED.  
 
 
 
 
 
 
 
47 
 
 
 
 
 
  
DISCUSSION 
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Discussion 
The evaluation of sexual function in patients following TURP has shown that TURP is 
associated with discordant outcomes, with relation to the risk of postoperative ED. One of the 
reasons related to different tools used for evaluation, the older studies were retrospective 
evaluation of sexual function and used a variety of tools which were not standardized for 
assessment of erectile function in the setting of a clinical trial. 
Impotence has been reported at a rate of 4–40% in several early studies but this rate now is 
thought to be an overestimation.  
Indian data on this is sparse, done with poorly validated questionnaires.  
The effect of TURP on erectile function in our study group, as assessed by IIEF questionnaire, 
showed a significant reduction of erectile function scores, pre-TURP mean values of 21.42 to 
20.97 & the overall sexual function as noted in IIEF scores from mean values of 52.07, to 
49.14.  
As detected in the multicenter American Urological Association Cooperative Study the 
prevalence of postoperative ED reported in a retrospective meta-analysis that included 3,304 
patients treated with TURP was 13.6%8.  
In contrast, results in a recent report of Leliefeld et al 9 84% did not report any change in 
sexual function and no significant differences were found among the groups of BPH, medical 
management & TURP for BPH. 
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On the other hand, the only study that compared watchful waiting with TURP demonstrated a 
20% lower rate of EF in the untreated group and did not show an increase in ED prevalence in 
the TURP group, which was monitored for up to 3 years after the procedure.48 
Comment on baseline parameters of age, LUTS on erectile function  
In our study subjects before TURP 77% had some degree of ED. In the age group of less than 
65 yr 25% had normal erectile function, mild ED & mild- moderate ED was seen in 70% and 
moderate – severe ED was seen in only 5% of patients.  
Those aged more than 65 yr only 14% had normal erectile function, 49% has mild Ed - 
moderate ED and 37% has moderate- severe ED.  
Worldwide the prevalence of ED, studies conducted between 1993 and 2003, stratified by age 
showed a rising prevalence of ED. Before age 40 the rate was 1% to 9%; from 40 to 59 it 
ranged from 2% to 9% to as high as 20% to 30%30. 
In the Massachusetts Male Aging Study (MMAS) study32, ED had a high prevalence with 
52% of men reporting some degree of erectile dysfunction—mild in 17.1%, moderate in 
25.2% and complete in 9.6s. %. The prevalence of complete ED was age-dependent, 
increasing from 5% for men aged 40 years to 15% for those aged 70 years. 
In the Massachusetts Male Aging Study MMAS (Johannes et al, 2000) a longitudinal study 
conducted between 1987 and 1997, the average age of men at baseline was 52.2 years & 
between the ages of 40 and 70 years, the probability of complete ED increased from 5.1% to 
15%, moderate dysfunction increased from 17% to 34%, and mild dysfunction remained 
constant at about 17%33. 
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In Multinational Survey of the Aging Male MASM-7 the prevalence of ED was 31%, 55%, 
and 76% in men aged 50 to 59 years, 60 to 69 years, and 70 to 80 years, respectively2. 
The above mentioned epidemiologic studies demonstrated a deterioration of sexual 
dysfunction with aging. Our data confirm the evidence of this relationship in aging men. 
Effect of LUTS on erectile function has been studied extensively and is found to be an 
independent risk factor for sexual dysfunction irrespective of age. It has been shown that 
worsening of erectile function is seen with progressively severe LUTS.  
The results of the population based studies of LUTS and ED cannot be extrapolated to patients 
in our study as the two groups are not comparable, this study group is expected to have higher 
degree of bothersome LUTS as the have an indication for TURP because of natural history of 
progression of BPH and a few patients have failed medical management. However, the mean 
IPSS score of this group was 16.1. 
Based on the patients’ self-assessments our data demonstrates that TURP very effectively 
alleviates bothersome LUTS due to BPH.  
The well-known complication of TURP on ejaculation70, that is, retrograde ejaculation or 
decreased ejaculate volume, was confirmed in our study.  
 In a population based prevalence study 52% of men aged 40–70 years have some degree of 
SD, and two thirds of these men have moderate to severe LUTS, as noted in Cologne Male 
Survey & multinational UrEpik study.  
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The relative risk of ED stratified by International Prostate Symptom Score (IPSS) ranged from 
a relative risk 1.0 at IPSS 0 to a 3.3 fold increase in relative risk for IPSS greater than 1921. 
Following TURP there was a change in the overall IIEF score and erectile function scores 
Our results suggest that there are 70% of patients (75 patients) maintained a stable erectile 
function following TURP. This data confirms the finding of stable erectile function following 
TURP as shown in prospective RCT by F MONTORSI 57et al & the study by Zhigang Zhao 
et. Al58. 
In our study, 9 patients (8.5%) of patients in the whole group experienced an improvement of 
their erectile function. 2 of 9 patients with moderate ED & 1 of 6 with severe Ed showed 
improvement in their erectile function. Possible factors contributing to this improvement 
could be improvement in the LUTS, improvement in the baseline ejaculatory dysfunction or 
discontinuation of medication for BPH contributing to ED. An improvement of erectile 
function has also been shown to occur in previous studies by Wasson et al48 & Brookes et al54. 
21.5% of patients (23 patients) showed deterioration in their erectile function. Of these 74% 
(17 of them) were in mild ED category and 22% of patients (5 patients) were of mild-
moderate ED group. 
Change of erectile function scores noted in different categories of erectile function.  
46% of patients with mild ED worsened to mild-moderate ED group and 16% of patients with 
mild-moderate ED worsened to moderate ED.  
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Subgroup analysis revealed that reduction in erectile function was significant only in age 
group above 65yr, a finding that was noted by Rete scholl et al40. 
Most studies report only on the incidence of de novo erectile dysfunction after TURP and not 
on the proportion of patients experiencing a change of sexual function. Our study 
demonstrated that reduction of erectile function occurred only in 2 categories of ED- mild ED 
& mild-moderate ED. This reduction in erectile function score did not correlate with 
occurrence of retrograde ejaculation. Incidence of retrograde ejaculation was similar across all 
categories of ED & in was also similar in groups with improved / stable / worsened erectile 
function following TURP.  
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CONCLUSION 
Salient outcomes noted in this study were 
1. TURP resulted in a reduction in the erectile function which was statistically significant 
in one fifth of patients. 
2.  A significant reduction was seen only in age group more than 65 yr & only those with 
Mild & Mild-moderate ED categories. This did not have a correlation with change in 
ejaculatory function. 
3. All patients with normal erectile function and those with age less than 65 yr 
maintained a stable erectile function. There was no deterioration in patients with 
category moderate ED groups.  
4. There is no risk of large scale deterioration of erectile function categories.  
5. No instance of de-novo complete ED was noted following TURP, only a small 
downgrading by 1 category of ED can be expected in selected patients.  
a. In the subgroups which had deterioration, the risk was of a small magnitude 
(down grading by one category) 
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Appendix 
IIEF questionnaire 
 
1. Over the past 4 weeks, how often were you able to have an erection during sexual activity? 
0.   no sexual activity 
1. almost never/ never 
2. a few times (much less than half the time) 
3. sometimes (about half the time) 
4. most times (much more than half the time) 
5. almost always/ always 
 
2. Over the past 4 weeks, when you had erections with sexual stimulation, how often were 
your erections hard enough for penetration? 
0.   no sexual activity 
1. almost never/ never 
2. a few times (much less than half the time) 
3. sometimes (about half the time) 
4. most times (much more than half the time) 
5. almost always/ always 
 
3. Over the past 4 weeks, when you attempted sexual intercourse, how often were you able to 
penetrate (enter) your partner? 
0.   did not attempt intercourse 
1. almost never/ never 
2. a few times (much less than half the time) 
3. sometimes (about half the time) 
4. most times (much more than half the time) 
5. almost always/ always 
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4. Over the past 4 weeks, during sexual intercourse, how often were you able to maintain 
your erection after you had penetrated (entered) your partner? 
0.   did not attempt intercourse 
1. almost never/ never 
2. a few times (much less than half the time) 
3. sometimes (about half the time) 
4. most times (much more than half the time) 
5. almost always/ always 
 
5. Over the past 4 weeks, during sexual intercourse, how difficult was it to maintain your 
erection to complete intercourse? 
0.  did not attempt intercourse 
1. extremely difficult 
2. very difficult 
3. difficult 
4. slightly difficult 
5. not difficult 
 
6. Over the past 4 weeks, how many times did you attempt sexual intercourse? 
0.   no attempts 
1. one to two attempts 
2. three to four attempts 
3. five to six attempts 
4. seven to ten attempts 
5. more than eleven attempts 
 
7. Over the past 4 weeks, when you attempted sexual intercourse, how often was it 
satisfactory for you? 
0. did not attempt intercourse 
1. almost never/ never 
2. a few times (much less than half the time) 
3. sometimes (about half the time) 
4. most times (much more than half the time) 
5. almost always/ always 
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8. Over the past 4 weeks, how much did you enjoy sexual intercourse? 
0.   no intercourse 
1. no enjoyment 
2. not very enjoyable 
3. fairly enjoyable 
4. highly enjoyable 
5. very highly enjoyable 
 
9. Over the past 4 weeks, when you had sexual stimulation or intercourse, how often did you 
ejaculate? 
0. did not attempt intercourse 
1. almost never/ never 
2. a few times (much less than half the time) 
3. sometimes (about half the time) 
4. most times (much more than half the time) 
5. almost always/ always 
 
10. Over the past 4 weeks, when you had sexual stimulation or intercourse, how often did 
you have the feeling of orgasm or climax? 
0. did not attempt intercourse 
1. almost never/ never 
2. a few times (much less than half the time) 
3. sometimes (about half the time) 
4. most times (much more than half the time) 
5. almost always/ always 
 
11. Over the past 4 weeks, how often did you feel sexual desire? 
1. almost never/ never 
2. a few times (much less than half the time) 
3. sometimes (about half the time) 
4. most times (much more than half the time) 
5. almost always/ always  
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12. Over the past 4 weeks, how would you rate your level of sexual desire? 
1. very low/ none at all 
2. low 
3. moderate 
4. high 
5. very high 
 
13. Over the past 4 weeks, how satisfied were you with your overall sex life? 
1. very dissatisfied 
2. moderately dissatisfied 
3. about equally satisfied and dissatisfied 
4. moderately satisfied 
5. very satisfied 
 
14. Over the past 4 weeks, how satisfied were you with the sexual relationship with your 
partner? 
1. very dissatisfied 
2. moderately dissatisfied 
3. about equally satisfied and dissatisfied 
4. moderately satisfied 
5. very satisfied 
 
15. Over the past 4 weeks, how do you rate your confidence that you could have and keep an 
erection? 
1. very low 
2. low 
3. moderate 
4. high 
5. very high 
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Scoring Algorithm for IIEF 
All items are scored in 5 domains as follows: 
Domain Items Range Score Max Score 
Erectile Function  1, 2, 3, 4, 5, 15   0-5 30 
Orgasmic Function 9, 10  0-5 10 
Sexual Desire  11, 12  0-5 10 
Intercourse 
Satisfaction 6, 7, 8  0-5 15 
Overall Satisfaction 13, 14  0-5 10 
Clinical Interpretation 
I. Erectile function total scores can be interpreted as follows: 
Score Interpretation 
0-6 Severe dysfunction 
  
7-12 Moderate dysfunction 
    
13-18 Mild to moderate dysfunction 
    
19-24 Mild dysfunction 
    
25-30  No dysfunction 
68 
 
 
69 
 
 
 
 
 
 
KEY WORDS 
ED   Erectile dysfunction  
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H. No Age IPSS QOL IIEF
Erectile 
function
Pre‐op1 post‐op2 Pre‐op post‐op Pre‐op Post‐op Pre
776386D 70 17 3 4 1 45 43 14
750180D 60 32 2 5 0 41 40 17
349394C  62 20 3 2 0 54 48 24
781762D 60 16 3 3 0 47 53 23
003270D 65 26 2 5 0 46 42 18
771992D 52 21 2 3 1 38 55 15
766772D 55 on cbd 2 3 0 24 28 7
763881D 68 11 1 2 1 54 45 20
787769D 69 13 4 2 1 44 33 16
777822D 62 17 4 4 0 53 49 23
008674B 55 27 2 6 1 74 67 30
783678D 61 23 2 5 3 45 39 17
779523D 65 17 3 4 1 52 54 21
702400D 54 on cbd 2 5 0 46 45 19
751456D 67 19 2 3 0 24 28 7
964615C 67 8 1 3 1 53 50 21
803449D 68 26 2 5 0 52 48 21
639393D 48 11 1 4 1 55 50 23
000612D 54 19 2 3 0 60 64 28
368389A 65 25 3 4 1 54 53 23
793394D 62 15 3 2 0 52 48 22
507353D 61 12 3 3 0 47 53 23
596571D 63 26 2 5 0 52 48 21
810943D 60 16 2 3 1 72 67 29
364432D 67 15 3 4 1 27 26 9
574802B 58 16 1 2 1 62 57 26
805546D 55 27 2 5 0 51 45 21
776207D 61 on cbd 2 3 1 58 54 25
816453D 59 13 4 2 0 62 57 25
573303D 60 23 2 4 0 65 62 27
798748D 66 9 1 4 1 64 58 29
790513D 70 cbd 1 5 1 62 62 27
500443C 62 25 9 4 2 57 44 23
767262D 55 23 2 4 1 68 62 29
735921D 58 11 1 4 1 55 50 23
760711D 53 21 2 4 1 58 57 24
677991D 67 11 1 4 1 52 45 20
740902D 62 11 3 4 2 47 45 22
755075D 50 on cbd 3 4 1 43 41 21
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691179D 53 24 2 5 0 50 44 20
775100D 66 on cbd 2 3 1 63 59 27
765419D 65 13 4 2 0 62 57 25
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689459D 66 9 1 4 1 64 58 29
754924D 52 cbd 1 5 1 62 62 27
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425927B 57 16 2 3 1 72 67 29
699732D 61 23 2 5 3 45 39 17
595499C 68 14 1 4 1 44 41 19
584364D 59 25 3 4 1 54 53 23
724576D 66 15 3 2 0 52 48 22
138099D 59 26 2 5 1 63 58 26
593204D 64 11 1 4 1 45 42 15
227169C 63 21 2 4 1 58 57 24
369467D 59 18 2 5 2 47 41 19
704391D 57 23 2 5 3 45 39 17
603327C 68 18 1 3 0 51 46 21
707151D 58 on cbd 1 4 1 64 58 29
722621D 55 13 1 4 0 64 65 30
005916C 59 19 2 3 0 60 64 28
697794D 53 25 3 4 1 54 53 23
725592D 58 15 3 2 0 52 48 22
704121D 63 12 3 3 0 47 53 23
717450D 64 26 2 5 0 52 48 21
706234D 68 on cbd 3 2 0 41 39 12
702866A 64 13 1 3 1 54 45 23
313508D 59 16 2 3 1 29 50 6
597249C 68 17 3 4 1 44 42 13
713206D 60 33 2 5 0 41 40 17
516278B 69 19 2 3 0 24 28 7
960271C 64 8 1 3 1 53 50 21
835001C 68 15 3 4 1 42 40 22
696725D 56 11 1 2 1 61 56 25
692498d 52 18 1 3 0 51 52 21
685973D 57 26 2 5 1 63 58 26
674257D 60 11 1 4 1 55 50 23
850936C 60 21 2 4 1 58 57 24
697067D 64 18 2 5 2 47 41 19
697024D 64 9 1 4 1 64 58 29
288049D 48 16 0 3 1 62 61 27
562710D 58 14 3 3 0 68 68 28
263996D 63 20 1 5 1 50 47 18
674067D 67 16 3 4 1 42 40 22
676173D 67 14 1 2 1 35 30 8
658865D  53 29 2 6 1 74 67 30
673378D 65 22 2 5 3 45 39 17
656373D    67 cbd 1 4 1 55 47 23
673781D 66 19 1 5 1 50 47 18
629614D 66 16 2 3 1 45 43 14
525303D 60 17 4 4 0 53 47 23
389654D 67 28 2 6 1 48 40 14
645883D 62 cbd 2 5 3 45 39 17
652184D 60 15 2 3 0 66 65 27
650908D 69 14 3 3 0 43 39 14
634339D 67 19 1 5 1 42 38 14
652982D 63 22 3 2 0 54 48 24
649406D  62 20 3 4 1 50 40 20
612979D  64 23 2 5 1 60 56 25
646624D 63 11 1 4 1 52 50 21
641440D 48 20 1 4 1 62 59 26
629368D 59 18 2 5 2 46 42 18
627767C 67 15 3 2 0 51 44 22
647990D  66 14 2 3 0 48 47 23
709897D 48 15 3 4 1 42 40 22
ED 
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pre TURP
Erectile 
function
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postTURP Intercourse Satisfacti Orgasm & ejaculationDesire 
post pre post pre post Pre Post
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1 21 2 8 8 9 7 6 6
1 24 1 6 8 4 5 8 9
2 18 2 7 7 9 5 6 5
3 24 1 5 10 6 5 6 8
4 9 4 6 6 3 5 6 5
2 16 2 11 10 9 6 8 8
3 14 3 7 6 7 4 7 5
1 21 2 7 8 8 6 8 8
0 28 0 14 14 10 6 10 9
2 15 3 8 8 7 5 6 4
2 21 2 9 11 8 6 7 8
2 19 2 7 8 9 6 5 7
4 9 4 6 6 3 5 6 5
2 22 1 8 8 9 6 7 7
2 21 2 8 8 9 5 7 6
1 22 1 10 9 8 5 6 6
0 29 0 9 12 9 7 6 8
1 22 1 9 8 8 8 6 7
1 21 2 8 8 9 7 6 6
1 24 1 6 8 4 5 8 9
2 21 2 8 8 9 5 7 6
0 27 0 14 12 9 8 10 10
4 8 4 4 5 5 3 5 5
0 27 0 11 12 9 6 8 8
2 19 2 8 7 9 6 7 7
1 24 1 9 9 8 6 7 7
1 25 1 11 11 9 5 9 8
0 27 0 12 13 10 6 7 7
0 29 0 9 7 10 8 8 6
0 27 0 12 12 8 7 7 8
1 19 2 9 8 8 4 9 7
0 28 0 13 12 10 6 8 8
1 22 1 10 9 8 5 6 6
1 24 1 10 10 9 8 7 7
2 17 2 10 9 8 5 6 6
1 22 1 8 7 6 5 5 5
2 22 1 4 5 5 3 7 6
1 26 0 11 12 9 6 8 8
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0 26 0 11 11 8 6 8 8
1 25 1 11 11 9 5 9 8
0 27 0 12 13 10 6 7 7
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0 27 0 12 12 8 7 7 8
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1 21 2 4 5 5 3 7 6
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1 21 2 8 8 9 7 6 6
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3 14 3 8 9 8 5 6 6
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2 14 3 9 10 8 6 6 9
0 29 0 9 7 10 8 8 6
0 29 0 10 13 9 6 7 8
0 29 0 9 12 9 7 6 8
1 22 1 9 8 8 8 6 7
1 21 2 8 8 9 7 6 6
1 24 1 6 8 4 5 8 9
2 21 2 8 8 9 5 7 6
3 13 3 9 8 7 6 6 6
1 19 2 9 9 7 4 8 7
4 19 2 5 9 7 8 6 7
3 14 3 9 10 6 4 8 7
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1 21 4 5 5 3 7 6 4
Overall 
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